You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Analgetic Dose

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refractory Solid Tumors, Relapsed Solid Tumors Trial in Beijing (KSX01-TCRT cell therapy)

Recruiting
  • Refractory Solid Tumors
  • Relapsed Solid Tumors
  • KSX01-TCRT cell therapy
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Nov 21, 2023

Tumors Trial in United States (GSK4524101, Niraparib)

Not yet recruiting
  • Neoplasms
  • San Francisco, California
  • +5 more
Oct 5, 2023

Acute Myeloid Leukemia, MDS Trial in United States (GLB-001)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +3 more
Nov 21, 2023

Rotavirus Infections, Diarrhea Trial (IRV on a 0- and 28-day schedule, IRV on a 0-, 28- and 56-day schedule, Placebo on Day 0,

Not yet recruiting
  • Rotavirus Infections
  • Diarrhea
  • IRV on a 0- and 28-day schedule
  • +3 more
  • (no location specified)
Oct 8, 2023

Myeloproliferative Tumors Trial (INCA033989)

Not yet recruiting
  • Myeloproliferative Neoplasms
  • (no location specified)
Sep 11, 2023

Transarterial Radioembolization in COlorectal MEtastasis of

Not yet recruiting
  • Transarterial Radioembolization
  • Therasphere
  • (no location specified)
Sep 7, 2023

Opioid Use Disorder Trial (buprenorphine/naloxone)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jul 10, 2023

HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)

Not yet recruiting
  • HPV Associated Cancers
  • New York, New York
  • +1 more
Apr 25, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Pain, Postoperative, Depression, Postpartum Trial in Pittsburgh (Dose Level 1, Dose Level 2, Dose Level 3)

Not yet recruiting
  • Pain, Postoperative
  • Depression, Postpartum
  • Dose Level 1
  • +3 more
  • Pittsburgh, Pennsylvania
    Magee Womens Hospital of UPMC
Jun 7, 2023

Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)

Not yet recruiting
  • Atrial Fibrillation
  • +3 more
  • low-dose rivaroxaban
  • Standard-dose rivaroxaban
  • (no location specified)
Oct 25, 2023

Solid Tumor, Colorectal Cancer, Sigmoid Colon Cancer Trial in Seoul (GB104(Level 1), GB104(Level 2), GB104(Level 3))

Recruiting
  • Solid Tumor
  • +5 more
  • GB104(Level 1)
  • +2 more
  • Seoul, Gangnam-gu, Korea, Republic of
    Samsung Medical Center
Jul 5, 2023

Late-Onset Neonatal Sepsis Trial in China (Piperacillin/tazobactam)

Recruiting
  • Late-Onset Neonatal Sepsis
  • Dongying, China
  • +9 more
Jul 31, 2023

Rett Syndrome Trial (TSHA-102)

Not yet recruiting
  • Rett Syndrome
  • TSHA-102
  • (no location specified)
Nov 21, 2023

Hepatocellular Carcinoma Trial in Shanghai (BC3402 injection, Durvalumab injection)

Not yet recruiting
  • Hepatocellular Carcinoma
  • BC3402 injection
  • Durvalumab injection
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Oct 26, 2023

Advanced Solid Tumors Trial in Beijing (WJB001)

Not yet recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023

Advanced Solid Tumors Trial (AMG 305)

Not yet recruiting
  • Advanced Solid Tumors
  • AMG 305
  • (no location specified)
Mar 24, 2023

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Healthy Subjects Trial in Beijing (, IBI355)

Not yet recruiting
  • Healthy Subjects
  • Beijing, Beijing, China
    Aerospace Center Hospital
Oct 26, 2023

Cannabis Trial in Netanya (THC/CBD S.E powder, THC/CBD oil)

Recruiting
  • Cannabis
  • THC/CBD S.E powder
  • THC/CBD oil
  • Netanya, Israel
    Laniado Hospital
Nov 27, 2023

Safety Issues, Efficacy, MTD Trial in Jilin (Sintilimab 200mg+MB07133 600mg)

Recruiting
  • Safety Issues
  • +2 more
  • Sintilimab 200mg+MB07133 600mg
  • Jilin, Changchun, China
    The First Hospital of Jilin University
Nov 17, 2023

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
  • Hefei, Anhui, China
  • +7 more
Jun 27, 2023

Primary Malignant Brain Tumor Trial in China (ABM-1310)

Not yet recruiting
  • Primary Malignant Brain Tumor
  • Beijing, Beijing, China
  • +3 more
May 28, 2023

Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Trial (TmPSMA-02 CAR T Cells)

Not yet recruiting
  • Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
  • TmPSMA-02 CAR T Cells
  • (no location specified)
Sep 13, 2023

Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Oct 25, 2023